Inveltys

Product NDC: 0065-9307
11-digit product format: 000659307
Labeler code: 0065
Product ID: 0065-9307_02b53b1c-e4e2-40eb-9283-073996bbee67
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Loteprednol Etabonate
Dosage form: SUSPENSION
Route: OPHTHALMIC
Labeler: Alcon Laboratories, Inc.
Application: NDA210565
Marketing category: NDA
Marketing start: 2026-04-16
Marketing end: 2026-09-30
Substance: LOTEPREDNOL ETABONATE
Active strength: 10 mg/mL
Pharmacologic classes: Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N210565-001	INVELTYS	LOTEPREDNOL ETABONATE	1%	SUSPENSION/DROPS / OPHTHALMIC		RLD, RS	2018-08-22

Orange Book patents#

Current patent rows page 1 of 1 · 14 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N210565-001	10058511	2033-05-03	U-2492	Drug product	2018-09-10
N210565-001	10646437	2033-05-03		Drug product	2020-06-11
N210565-001	10688045	2033-05-03		Drug product	2020-07-16
N210565-001	10864219	2033-05-03	U-3011		2020-12-28
N210565-001	11219597	2033-05-03	U-3278		2022-01-21
N210565-001	11219597	2033-05-03	U-3279		2022-01-21
N210565-001	11642317	2033-05-03		Drug product	2023-05-31
N210565-001	11872318	2033-05-03		Drug product	2024-02-01
N210565-001	12115246	2033-05-03	U-4025	Drug product	2024-11-08
N210565-001	9056057	2033-05-03	U-2491	Drug product	2018-09-10
N210565-001	9393213	2033-05-03		Drug product	2018-09-10
N210565-001	9532955	2033-05-03	U-2491		2018-09-10
N210565-001	9737491	2033-05-03	U-2492		2018-09-10
N210565-001	9827191	2033-05-03	U-2493	Drug product	2018-09-10

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N210565-001	INVELTYS	1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2018-08-22	`e64feba35796…`

Observed Orange Book patent history#

Patent history page 1 of 12 · 480 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-08-18 06:07:40	2026-07	N210565-001	10058511	2033-05-03	U-2492	Drug product	2018-09-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210565-001	10646437	2033-05-03		Drug product	2020-06-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210565-001	10688045	2033-05-03		Drug product	2020-07-16	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210565-001	10864219	2033-05-03	U-3011		2020-12-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210565-001	11219597	2033-05-03	U-3278		2022-01-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210565-001	11219597	2033-05-03	U-3279		2022-01-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210565-001	11642317	2033-05-03		Drug product	2023-05-31	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210565-001	11872318	2033-05-03		Drug product	2024-02-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210565-001	12115246	2033-05-03	U-4025	Drug product	2024-11-08	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210565-001	9056057	2033-05-03	U-2491	Drug product	2018-09-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210565-001	9393213	2033-05-03		Drug product	2018-09-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210565-001	9532955	2033-05-03	U-2491		2018-09-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210565-001	9737491	2033-05-03	U-2492		2018-09-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210565-001	9827191	2033-05-03	U-2493	Drug product	2018-09-10	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N210565-001	10058511	2033-05-03	U-2492	Drug product	2018-09-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210565-001	10646437	2033-05-03		Drug product	2020-06-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210565-001	10688045	2033-05-03		Drug product	2020-07-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210565-001	10864219	2033-05-03	U-3011		2020-12-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210565-001	11219597	2033-05-03	U-3278		2022-01-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210565-001	11219597	2033-05-03	U-3279		2022-01-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210565-001	11642317	2033-05-03		Drug product	2023-05-31	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210565-001	11872318	2033-05-03		Drug product	2024-02-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210565-001	12115246	2033-05-03	U-4025	Drug product	2024-11-08	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210565-001	9056057	2033-05-03	U-2491	Drug product	2018-09-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210565-001	9393213	2033-05-03		Drug product	2018-09-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210565-001	9532955	2033-05-03	U-2491		2018-09-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210565-001	9737491	2033-05-03	U-2492		2018-09-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210565-001	9827191	2033-05-03	U-2493	Drug product	2018-09-10	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210565-001	10058511	2033-05-03	U-2492	Drug product	2018-09-10	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210565-001	10646437	2033-05-03		Drug product	2020-06-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210565-001	10688045	2033-05-03		Drug product	2020-07-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210565-001	10864219	2033-05-03	U-3011		2020-12-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210565-001	11219597	2033-05-03	U-3278		2022-01-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210565-001	11219597	2033-05-03	U-3279		2022-01-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210565-001	11642317	2033-05-03		Drug product	2023-05-31	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210565-001	11872318	2033-05-03		Drug product	2024-02-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210565-001	12115246	2033-05-03	U-4025	Drug product	2024-11-08	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210565-001	9056057	2033-05-03	U-2491	Drug product	2018-09-10	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210565-001	9393213	2033-05-03		Drug product	2018-09-10	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210565-001	9532955	2033-05-03	U-2491		2018-09-10	`31067a03dcf5…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N210565-001	NP	2021-08-22	`74a2ff9319b5…`
2021-12-28 21:50 UTC	2021-12	N210565-001	NP	2021-08-22	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N210565-001	NP	2021-08-22	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N210565-001	NP	2021-08-22	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N210565-001	NP	2021-08-22	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N210565-001	NP	2021-08-22	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N210565-001	NP	2021-08-22	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N210565-001	NP	2021-08-22	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N210565-001	NP	2021-08-22	`ea99ee380514…`

Additional Listing Data#

Finished product: Yes
Brand name base: Inveltys

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
LOTEPREDNOL ETABONATE	10 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
YEH1EZ96K6	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
2055281	Internal RxNorm lookup
2055286	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
bdd18e84-79b3-4c8b-a07f-eb06cf52e68c	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
4f474382-f6ee-e00d-5df3-bba50cddfd89	Product name	5	20251114
64ba4d79-5363-eefc-3390-ee5d2a50a350	Product name	3	20250304
100e83dc-ec8c-9e2e-76d2-5112415ec972	Product name	3	20241008
4300453c-d545-46d1-b115-18b12b4ccf79	Product name	1	20210525
3f316f1c-2561-47c9-9865-ba2be69e0b3e	Product name	1	20190614
f1ee2aaf-88da-4841-948b-7d3a6af14e35	Product name	1	20181206
aa1cd319-ece7-51f7-3a9d-52a64f5f4e81	Product name	1	20140508
b5c5cd73-a27b-5e41-bd36-3de9471473cd	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0065-9307-04	Inveltys	1 in 1 CARTON	SUSPENSION	1	1
0065-9307-04	Inveltys	2.8 mL in 1 BOTTLE, DROPPER	SUSPENSION	2.8	1
0065-9307-05	Inveltys	2.8 mL in 1 BOTTLE, DROPPER	SUSPENSION	2.8	1
0065-9307-05	Inveltys	1 in 1 CARTON	SUSPENSION	1	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Inveltys	LOTEPREDNOL ETABONATE	Alcon Laboratories, Inc.	bdd18e84-79b3-4c8b-a07f-eb06cf52e68c	2026-07-01	Warnings, Adverse reactions	Exact identifier application applno (NDA): 210565 application number: NDA210565 ndc (product): 0065-9307
Inveltys	LOTEPREDNOL ETABONATE	ALCON LABORATORIES, INC.	2ec16df8-2e5c-4e06-8d28-21df76f27d72	2026-07-01	Warnings, Adverse reactions	Exact identifier application applno (NDA): 210565 application number: NDA210565

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
YEH1EZ96K6	LOTEPREDNOL ETABONATE	82034-46-6	LOTEPREDNOL ETABONATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
2055286	INVELTYS 1 % Ophthalmic Suspension	PSN	bdd18e84-79b3-4c8b-a07f-eb06cf52e68c	1
2055281	loteprednol etabonate 1 % Ophthalmic Suspension	PSN	bdd18e84-79b3-4c8b-a07f-eb06cf52e68c	1
2055286	loteprednol etabonate 10 MG/ML Ophthalmic Suspension [Inveltys]	SBD	bdd18e84-79b3-4c8b-a07f-eb06cf52e68c	1
2055281	loteprednol etabonate 10 MG/ML Ophthalmic Suspension	SCD	bdd18e84-79b3-4c8b-a07f-eb06cf52e68c	1
2055286	Inveltys 1 % Ophthalmic Suspension	SY	bdd18e84-79b3-4c8b-a07f-eb06cf52e68c	1
2055286	Inveltys 10 MG/ML Ophthalmic Suspension	SY	bdd18e84-79b3-4c8b-a07f-eb06cf52e68c	1
2055281	loteprednol etabonate 1 % Ophthalmic Suspension	SY	bdd18e84-79b3-4c8b-a07f-eb06cf52e68c	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0065-9307-04	00065930704	1 BOTTLE, DROPPER in 1 CARTON (0065-9307-04) / 2.8 mL in 1 BOTTLE, DROPPER	2026-04-16	2026-09-30	No	No	Historical
0065-9307-05	00065930705	1 BOTTLE, DROPPER in 1 CARTON (0065-9307-05) / 2.8 mL in 1 BOTTLE, DROPPER	2026-04-16	2026-09-30	Yes	No	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Inveltys	Alcon Laboratories, Inc. \| Alcon Research LLC \| Industriale Chimica SRL	2026-07-01	HUMAN PRESCRIPTION DRUG LABEL	2